Lilly-backed Forbion raises $2.6B in largest-ever fundraise
The Dutch life sciences investor raised €2.3 billion ($2.6 billion) across two funds, marking its largest capital haul to date.
Palanor Wire · composed from 3 outlets · every claim links to its sources
What happened
Forbion raised €2.3 billion ($2.6 billion) across two funds. 123 The haul is the firm's largest fundraising to date. 123 Eli Lilly provided backing for the raise. 3 Forbion plans to deploy the capital to about 30 companies. 3
Why it matters
The raise provides a lift for the European biotech industry. 1 European biotech has fallen behind its counterparts in the U.S. and China. 1 The fundraise highlights challenges facing European biotech investment. 2
Sources · 3
[1]Forbion, a prominent biotech investor, raises $2.6B for a pair of venture funds
BioPharma Dive
[2]Forbion gets Lilly's backing in Dutch VC's largest-ever fundraising haul
Endpoints News
[3]Forbion Raises €2.3 Billion, Highlighting European Biotech Investment Challenges
gurufocus.com · via Marketaux
Matched signals
Lattice signals Numen pinned to this story at publish time.
No matched signals on this story.
Unlock the analytical widgets on every article — signal matches, Trends snapshots, X overlays, agent reasoning — with a Member account.
Upgrade →On X right now
Top engagement posts about this topic, ranked by likes + retweets + quotes.
No high-engagement X posts captured for this topic. Either the topic is too quiet or the upstream API was unavailable when this article published.
Unlock the analytical widgets on every article — signal matches, Trends snapshots, X overlays, agent reasoning — with a Member account.
Upgrade →Your read
How did this article land?
Three sliders. Optional comment. Anonymous is fine.
Open to anyone. One response per reader.